Plasma Collection Machines (PCM) Market Size, Share & Trends Analysis Report By Product (Desk Type Plasma Collection Machine (PCM), Trolley Type Plasma Collection Machine (PCM)), By Applications (Hospitals, Blood Center, Others), By End Use, By Region, and Segment Forecasts - 2035

Plasma Collection Machines (PCM) Market Overview

plasma collection machines (pcm) market size was valued at USD 374.62 million in 2025 and is poised to grow from USD 386.61 million in 2026 to USD 517.23 million by 2035, growing at a CAGR of 3.2% during the forecast period (2026-2035).

The Plasma Collection Machines (PCM) Market is expanding steadily as healthcare systems increase demand for efficient plasma collection technologies to support plasma-derived therapies and blood component processing. Growing requirements for plasma-based medicines, increasing awareness of plasma donation, and improvements in automated collection systems are influencing market development. In 2026, more than 60% of modern blood collection facilities are expected to evaluate advanced plasma collection equipment to improve operational efficiency, donor management, and collection capacity. Manufacturers are focusing on improving machine automation, donor comfort, processing speed, and system reliability to meet evolving healthcare requirements.

The United States represents a significant market for Plasma Collection Machines (PCM) due to advanced healthcare infrastructure, established plasma donation networks, and strong demand for plasma-derived therapies. In 2026, nearly 70% of large plasma collection centers are expected to utilize automated collection systems to improve collection efficiency and maintain high-quality plasma supply. Increasing investment in blood center modernization, rising demand for immunoglobulin therapies, and expansion of plasma donation programs are supporting market growth across the country.

• 

  Download Free sample to learn more about this report.

Key Findings

• Leading Product Type: Trolley Type Plasma Collection Machine (PCM) is expected to hold the largest market share during the forecast period, supported by mobility advantages and accounting for nearly 60% adoption in high-volume collection facilities.
• Leading Application: Blood Center applications are projected to dominate market demand with approximately 65% adoption due to increasing plasma donation activities and growing demand for plasma-derived therapies.
• Leading Region: North America is expected to lead the market with nearly 40% share due to advanced plasma collection infrastructure and strong healthcare investment.
• Fastest Growing Region: Asia Pacific is projected to witness the fastest growth with around 7% annual expansion driven by increasing healthcare infrastructure and plasma collection programs.
• Technology Trend: Automated plasma collection systems are shaping the market, with more than 50% of newly developed machines incorporating digital monitoring and workflow optimization features.
• Market Driver: Rising demand for plasma-derived therapies is supporting growth, with global plasma collection activities increasing as healthcare providers expand treatment availability.
• Competitive Landscape: Companies are enhancing machine capabilities through automation and product innovation, with leading manufacturers introducing more than 10 equipment improvements between 2024 and 2026.
• Future Outlook: The market is moving toward smarter collection technologies, with approximately 65% of plasma centers expected to prioritize automated and connected collection systems.

Latest Trends

The Plasma Collection Machines (PCM) Market is increasingly influenced by automation, digital monitoring, and improvements in donor-focused collection technologies. Healthcare organizations are adopting advanced machines that improve plasma collection efficiency, reduce processing time, and enhance donor experience. In 2026, more than 55% of plasma collection facilities upgrading their equipment are expected to prioritize systems with improved automation and data management capabilities. These developments are supporting higher collection capacity while maintaining quality and safety standards.

Another major trend is the increasing integration of smart healthcare technologies into plasma collection equipment. Manufacturers are developing systems with enhanced monitoring, automated control functions, and improved workflow management features. Approximately 50% of new plasma collection equipment developments are expected to include digital capabilities that support operational tracking and process optimization. The increasing demand for plasma-derived medicines is encouraging healthcare providers to invest in advanced collection infrastructure.

Market Dynamics

Driver

""Growing demand for plasma-derived therapies and blood products.""

The increasing requirement for plasma-derived therapies is a major factor driving the Plasma Collection Machines (PCM) Market. Plasma is essential for producing important therapeutic products, including immunoglobulins and other plasma-based treatments. Healthcare providers are expanding plasma collection capabilities to meet rising treatment demand. In 2026, more than 60% of plasma collection organizations are expected to invest in equipment upgrades to increase operational efficiency and collection capacity.

The expansion of plasma donation programs is also strengthening market demand. Automated plasma collection machines allow centers to improve collection consistency, reduce manual workload, and support better donor management. Approximately 65% of plasma centers are focusing on advanced collection technologies to improve productivity and maintain high-quality plasma supply.

Restraint

""High equipment costs limit adoption among smaller facilities.""

The high cost of plasma collection machines remains a key challenge affecting adoption, particularly among smaller blood centers and healthcare organizations. Advanced plasma collection systems require significant investment in equipment purchase, installation, maintenance, and staff training. Nearly 40% of smaller facilities consider equipment affordability a major factor when evaluating new plasma collection technologies.

Maintenance requirements and technical support needs can also influence adoption decisions. Healthcare organizations require trained personnel and reliable service networks to ensure continuous equipment operation. Approximately one-third of plasma collection facilities identify operational support requirements as an important consideration before investing in advanced systems.

Opportunity

""Expansion of plasma collection infrastructure creates growth opportunities.""

The expansion of plasma collection infrastructure across emerging markets creates significant opportunities for PCM manufacturers. Increasing healthcare investment, growing awareness of plasma donation, and rising demand for plasma therapies are encouraging countries to develop stronger collection networks. More than 50% of new healthcare infrastructure projects in developing regions are expected to consider advanced blood processing technologies.

The adoption of automated systems in blood centers also creates additional opportunities for market participants. Healthcare providers are seeking machines that improve efficiency, reduce processing challenges, and support larger collection volumes. Approximately 60% of blood centers planning technology upgrades are evaluating automated plasma collection solutions.

Challenge

""Complex regulatory requirements affect market expansion.""

Regulatory compliance and quality standards represent significant challenges for Plasma Collection Machines (PCM) manufacturers and healthcare providers. Equipment must meet strict safety, performance, and quality requirements before being adopted in clinical environments. Nearly 45% of manufacturers consider regulatory approval processes a major factor affecting product development timelines.

Maintaining consistent plasma quality and ensuring efficient equipment integration also create operational challenges. Blood centers require reliable systems that fit existing workflows while maintaining donor safety and collection accuracy. Around 40% of healthcare organizations prioritize compatibility, reliability, and regulatory compliance when selecting plasma collection equipment.

• 

  Download Free sample to learn more about this report.

Segmentation Analysis

By Types

Desk Type Plasma Collection Machine (PCM): Desk Type Plasma Collection Machine (PCM) represents an important product segment due to its compact structure, efficient operation, and suitability for smaller blood collection environments. This segment is expected to account for nearly 40% of market demand during the forecast period. These systems are preferred by facilities requiring space-efficient plasma collection solutions with reliable performance. More than 45% of smaller collection centers and clinics evaluating plasma collection equipment are expected to consider desk type systems due to their operational convenience and lower space requirements.

Trolley Type Plasma Collection Machine (PCM): Trolley Type Plasma Collection Machine (PCM) is expected to dominate the market due to its mobility, flexibility, and suitability for high-volume plasma collection environments. This segment is projected to account for approximately 60% of market adoption during the forecast period. Trolley systems allow healthcare facilities to improve workflow flexibility and support multiple collection locations. More than 65% of large blood centers are expected to prioritize trolley type machines because of their operational advantages and ability to support expanding plasma collection activities.

By Applications

Hospitals: Hospitals represent a significant application segment in the Plasma Collection Machines (PCM) Market as healthcare facilities increasingly require advanced blood processing and plasma collection capabilities. This segment is expected to account for nearly 25% of market demand during the forecast period. Hospitals are adopting plasma collection technologies to support specialized treatments, improve blood management processes, and strengthen healthcare infrastructure. Approximately 50% of hospitals investing in blood processing upgrades are expected to evaluate automated plasma collection solutions.

Blood Center: Blood Center applications are expected to remain the leading segment, accounting for approximately 65% of total market demand during the forecast period. Plasma collection centers require high-efficiency machines to support large-scale plasma donation programs and maintain consistent supply for plasma-derived therapies. More than 70% of plasma collection facilities are expected to invest in advanced collection equipment to improve donor throughput, operational efficiency, and plasma quality management.

Others: Others applications include specialized healthcare facilities, research organizations, and medical institutions requiring plasma collection capabilities. This segment is projected to contribute nearly 10% of market adoption during the forecast period. Increasing research activities and specialized medical applications are supporting demand for flexible plasma collection solutions. Around 35% of specialty healthcare facilities are exploring compact plasma collection technologies to improve operational capabilities.

• 

  Download Free sampleto learn more about this report.

Regional Outlook

North America: North America is expected to maintain its leading position in the Plasma Collection Machines (PCM) Market due to advanced healthcare infrastructure, strong plasma donation networks, and high demand for plasma-derived therapies. The region is projected to account for nearly 40% of market participation during the forecast period. The United States represents the largest contributor due to established blood collection systems and continuous investment in plasma center expansion.

The region benefits from advanced medical technology adoption, strong regulatory standards, and increasing demand for efficient plasma collection systems. In 2026, more than 70% of major plasma collection facilities in North America are expected to utilize automated equipment to improve collection capacity and operational efficiency. Healthcare organizations are increasingly focusing on modernizing collection infrastructure to meet rising therapeutic plasma demand.

Europe: Europe represents a significant market for Plasma Collection Machines (PCM) due to developed healthcare systems, increasing plasma donation awareness, and strong emphasis on blood safety standards. The region is expected to contribute approximately 30% of market demand during the forecast period. Countries including Germany, France, the United Kingdom, and Italy are key contributors due to advanced healthcare facilities and established blood management systems.

European healthcare organizations are increasingly adopting automated plasma collection technologies to improve collection efficiency and maintain quality standards. Nearly 60% of plasma collection centers in developed European markets are expected to evaluate equipment upgrades during the forecast period. Growing demand for plasma-derived medicines and improved healthcare infrastructure are supporting regional market growth.

Asia Pacific: Asia Pacific is projected to experience the fastest growth in the Plasma Collection Machines (PCM) Market due to expanding healthcare infrastructure, increasing plasma donation programs, and rising investment in medical technologies. The region is expected to achieve around 7% annual growth during the forecast period. Countries such as China, India, Japan, and South Korea are contributing significantly to regional expansion.

The increasing development of blood centers and healthcare facilities is creating strong opportunities for plasma collection equipment manufacturers. More than 50% of newly developed healthcare projects in emerging Asian markets are expected to include advanced blood processing technologies. Growing awareness of plasma therapies and increasing healthcare spending are accelerating adoption across the region.

Latin America: Latin America is witnessing gradual growth in the Plasma Collection Machines (PCM) Market as healthcare systems improve blood collection capabilities and increase investment in medical infrastructure. The region is expected to represent nearly 5% of market adoption during the forecast period. Brazil and Mexico are among the important contributors due to expanding healthcare networks.

Healthcare organizations in Latin America are increasingly focusing on improving plasma collection efficiency and strengthening blood supply systems. Approximately 40% of healthcare facilities planning modernization projects are expected to consider advanced plasma collection equipment. Increasing demand for plasma-based therapies is creating additional opportunities for market development.

Middle East & Africa: The Middle East & Africa region is expected to witness steady growth due to healthcare infrastructure development, increasing medical investments, and improving blood collection capabilities. The region is projected to account for approximately 5% of market demand during the forecast period.

Hospitals and blood centers across the region are gradually adopting modern plasma collection systems to improve healthcare services and support growing treatment requirements. More than 35% of healthcare organizations investing in modernization initiatives are expected to evaluate advanced plasma collection technologies. Increasing awareness of plasma donation and healthcare expansion programs are supporting regional growth.

List of Top Plasma Collection Machines (PCM) Companies

• Terumo BCT
• Fresenius Kabi
• Haemonetics
• Asahi Kasei Medical
• Nikkiso
• B. Braun
• Miltenyi Biotec
• Kaneka Medix
• Nigale
• Haier Biomedical
• Scinomed
• Medica SPA
• Shanghai Dahua Medical Equipment

Top 2 Companies Market Share

Terumo BCT: Terumo BCT maintains a strong position in the Plasma Collection Machines (PCM) Market through its advanced blood component technology solutions, automated collection systems, and global healthcare presence. The company focuses on improving plasma collection efficiency, donor experience, and operational reliability for blood centers worldwide. In 2026, more than 65% of large plasma collection facilities are expected to prioritize automated systems that improve collection productivity and workflow management. Terumo BCT continues to enhance its product portfolio through technology improvements, system integration, and solutions designed to support increasing demand for plasma-derived therapies.

Haemonetics: Haemonetics is a prominent participant in the Plasma Collection Machines (PCM) Market, providing blood management technologies and automated plasma collection solutions for healthcare organizations. The company focuses on improving blood processing efficiency, collection accuracy, and healthcare workflow optimization. In 2026, approximately 60% of plasma centers upgrading their equipment are expected to evaluate systems offering improved automation, monitoring capabilities, and operational efficiency. Haemonetics continues to strengthen its market position through innovation, product development, and solutions supporting modern plasma collection requirements.

Investment Analysis

The Plasma Collection Machines (PCM) Market is attracting investment as healthcare organizations increase focus on plasma supply expansion, blood component processing, and advanced collection technologies. Manufacturers are investing in automated systems, improved machine reliability, and digital monitoring capabilities to meet growing demand from blood centers and hospitals. In 2026, more than 55% of healthcare technology investments in plasma collection are expected to focus on improving collection efficiency, reducing operational challenges, and enhancing donor management processes.

Investment opportunities are also increasing due to expansion of plasma collection infrastructure in emerging markets and rising demand for plasma-derived therapies. Companies are allocating resources toward manufacturing expansion, regional distribution networks, and development of flexible equipment solutions. Approximately 60% of blood collection organizations planning technology upgrades are expected to consider advanced plasma collection machines as part of modernization initiatives. Increasing healthcare investment and growing plasma donation programs are expected to support continued market development.

New Product Development

New product development in the Plasma Collection Machines (PCM) Market is focused on automation, improved donor comfort, enhanced data management, and higher collection efficiency. Manufacturers are introducing advanced machines with improved monitoring systems, optimized workflows, and better compatibility with plasma processing requirements. In 2026, nearly 50% of newly developed plasma collection systems are expected to include digital features that support operational tracking and process improvement.

Companies are also developing compact and flexible plasma collection solutions suitable for different healthcare environments, including hospitals, blood centers, and specialty facilities. New equipment designs emphasize mobility, ease of operation, and improved collection accuracy. More than 55% of healthcare providers adopting new plasma collection technologies are expected to prefer systems that provide automation, reliability, and improved workflow integration.

Five Recent Developments

• February 2026 Automated Collection System Enhancement: Plasma collection equipment manufacturers introduced improved automation features and digital monitoring capabilities to increase collection efficiency, with more than 50% of new systems focusing on workflow optimization and operational tracking.
• October 2025 Plasma Technology Upgrade: Companies enhanced plasma collection machines with improved donor management functions, higher processing efficiency, and advanced safety features to support expanding plasma donation programs across healthcare facilities.
• June 2025 Smart Healthcare Integration Development: Market participants expanded connected plasma collection technologies by introducing improved data management and monitoring capabilities, helping blood centers improve operational visibility and equipment utilization.
• March 2025 Product Portfolio Expansion: Plasma equipment providers increased focus on flexible collection solutions by developing systems suitable for hospitals, blood centers, and specialty healthcare environments with improved workflow adaptability.
• August 2024 Regional Healthcare Infrastructure Expansion: Companies strengthened distribution strategies and expanded plasma collection equipment availability as healthcare organizations increased investments in blood processing technologies and plasma therapy support systems.

Report Coverage

The Plasma Collection Machines (PCM) Market report provides a comprehensive assessment of industry trends, market dynamics, segmentation analysis, regional developments, competitive strategies, and technological advancements influencing market growth. The report covers key product types including Desk Type Plasma Collection Machine (PCM) and Trolley Type Plasma Collection Machine (PCM), along with major applications such as Hospitals, Blood Center, and Others. It evaluates the increasing importance of automated plasma collection technologies in supporting plasma-derived therapies and improving healthcare efficiency.

The report coverage also analyzes market drivers, restraints, opportunities, challenges, investment trends, and product innovation strategies shaping the future of the industry. It highlights the growing role of automation, digital monitoring, healthcare infrastructure expansion, and advanced blood processing technologies. As healthcare providers continue improving plasma collection capacity and adopting modern medical equipment, the market is expected to experience steady development through 2035 with increasing focus on efficiency, reliability, and scalable collection solutions.